Additionally, we observed significantly reduced mRNA expression levels of CCND1, p15INK4b, and RB in prostate tumor tissues compared to BPH tissues, while the expression levels of CDK4, CDK6, and p16INK4a remained unaltered. Here, CDKN2A is linked to benign prostatic hyperplasia.